Latest Cancer News

Gilteritinib Approved for Advanced Acute Myeloid Leukemia (AML) with a FLT3 Mutation (11-29-2018)
The U.S. Food and Drug Administration approved Xospata (gilteritinib) for treatment of adult patients who have recurrent or refractory acute myeloid leukemia (AML) with a FLT3 mutation. About Xospata Xospata... Continue Reading

Tissue “Agnostic” Genomic Based Treatment With Vitrakvi and Keytruda – A Paradigm Shift in Cancer Treatment (11-28-2018)
The US Food and Drug Administration (FDA) on Monday approved a new precision cancer medicine Vitrakvi (larotrectinib) for the treatment of adult and pediatric solid tumors that have a targetable biomarker... Continue Reading

FDA Approves Venclexta Combination for AML in Adults (11-26-2018)
The Food and Drug Administration granted accelerated approval to Venclexta (venetoclax) in combination with azacitidine or decitabine or low-dose cytarabine for the treatment of newly-diagnosed acute myeloid... Continue Reading

More Cancer News

Locations

 

Lake Worth, FL
3450 Lantana Rd. Suite 100
Lake Worth, FL 33462
561.965-1864

Boynton Beach, FL
2300 S. Congress Ave Suite 103
Boynton Beach, FL 33426
561.732-2440

 

Loxahatchee, FL
12993 Southern Blvd., Suite B
Loxahatchee, FL 33470
561.793-0106